The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunotherapy related patient-reported outcomes from five randomized controlled trials in patients with triple negative breast cancer: A systematic review.
 
Carrie Sha
No Relationships to Disclose
 
Marie Liu
No Relationships to Disclose
 
Johanna Goldberg
No Relationships to Disclose
 
Larry Norton
Stock and Other Ownership Interests - Codagenix
Honoraria - ABC7 Global Alliance Conference; Blackrock QLS Advisors; BrightEdge-CancerRx Meeting at MIT; Bristol-Myers Squibb/Celgene; Codagenix; Cold Spring Harbor Laboratory; CSHL; Dominguez V. United States; Isom Lecture Seminar at UTSW; MSK Pharma; NCI Reviews; TGH Cancer Institute; Third Annual NYOH Breast Cancer Symposium; Transgender and non-binary Breast Cancer Education; UNC Breast Spore EAB Meeting
Consulting or Advisory Role - Agenus; Blackrock, Inc; Codagenix; IMMIX BIOPHARMA, INC.
Expert Testimony - Dominguez V. United States
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - Artios (Inst); AstraZeneca (Inst); Merck (Inst); Pfizer (Inst); Zenith Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clinical Care Options; Clinical Education Alliance; MJH Healthcare Holdings, LLC; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; GlaxoSmithKline; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Iris Zhi
No Relationships to Disclose